MedCity News December 16, 2025
Dr. Prajnan Das, department chair of Gastrointestinal (GI) Radiation Oncology at MD Anderson Cancer Center, talks about how precision medicine has evolved and how AI may actually be the technology that supercharges the conversion of the knowledge about human biology to personalized treatments that work.
Ever since early February, when former FDA Commissioner Robert Califf publicly bemoaned the progress of precision medicine, I wanted to find out whether other people felt similarly discouraged.
I got my chance in October when an MD Anderson Cancer Center public relations professional pitched an interview with a senior MD Anderson radiation oncologist, who just happened to be my dearly departed brother’s close friend. In fact, Dr. Prajnan Das, professor and department chair of Gastrointestinal...
Today's Sponsors
Today's Sponsor